pyridoxine 5'-phosphate

Suppliers

Names

[ CAS No. ]:
447-05-2

[ Name ]:
pyridoxine 5'-phosphate

[Synonym ]:
Pyridoxol,5-(dihydrogen phosphate)
Phosphorsaeure-mono-(5-hydroxy-4-hydroxymethyl-6-methyl-[3]pyridylmethylester)
phosphoric acid mono-(5-hydroxy-4-hydroxymethyl-6-methyl-[3]pyridylmethyl ester)
Pyridoxol 5-phosphate
Pyridoxyl-5-phosphate
[5-hydroxy-4-(hydroxymethyl)-6-methylpyridin-3-yl]methyl dihydrogen phosphate
Pyridoxine phosphate
pyridoxine-P
pyridoxine-5'-phosphate

Chemical & Physical Properties

[ Density]:
1.628g/cm3

[ Boiling Point ]:
638.5ºC at 760mmHg

[ Melting Point ]:
123-126ºC

[ Molecular Formula ]:
C8H12NO6P

[ Molecular Weight ]:
249.15800

[ Flash Point ]:
340ºC

[ Exact Mass ]:
249.04000

[ PSA ]:
129.92000

[ LogP ]:
0.19720

[ Vapour Pressure ]:
3.54E-17mmHg at 25°C

[ Index of Refraction ]:
1.625

Toxicological Information

CHEMICAL IDENTIFICATION

RTECS NUMBER :
UV1340000
CHEMICAL NAME :
Pyridoxol, 5-(dihydrogen phosphate)
CAS REGISTRY NUMBER :
447-05-2
BEILSTEIN REFERENCE NO. :
0233737
LAST UPDATED :
199612
DATA ITEMS CITED :
4
MOLECULAR FORMULA :
C8-H12-N-O6-P

HEALTH HAZARD DATA

ACUTE TOXICITY DATA

TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Intraperitoneal
SPECIES OBSERVED :
Rodent - rat
DOSE/DURATION :
7400 mg/kg
TOXIC EFFECTS :
Behavioral - convulsions or effect on seizure threshold
REFERENCE :
GNRIDX Gendai no Rinsho. (Tokyo, Japan) V.1-10, 1967-76(?). Volume(issue)/page/year: 1,493,1967
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Oral
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
7800 mg/kg
TOXIC EFFECTS :
Sense Organs and Special Senses (Eye) - ptosis Behavioral - tremor Behavioral - ataxia
REFERENCE :
GNRIDX Gendai no Rinsho. (Tokyo, Japan) V.1-10, 1967-76(?). Volume(issue)/page/year: 1,493,1967
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Intraperitoneal
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
5600 mg/kg
TOXIC EFFECTS :
Sense Organs and Special Senses (Eye) - ptosis Behavioral - altered sleep time (including change in righting reflex) Behavioral - convulsions or effect on seizure threshold
REFERENCE :
GNRIDX Gendai no Rinsho. (Tokyo, Japan) V.1-10, 1967-76(?). Volume(issue)/page/year: 1,493,1967
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Subcutaneous
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
7100 mg/kg
TOXIC EFFECTS :
Sense Organs and Special Senses (Eye) - ptosis Behavioral - tremor Behavioral - ataxia
REFERENCE :
GNRIDX Gendai no Rinsho. (Tokyo, Japan) V.1-10, 1967-76(?). Volume(issue)/page/year: 1,493,1967

Safety Information

[ HS Code ]:
2933399090

Synthetic Route

Click to get detail synthetic route

Precursor & DownStream

Precursor

  • Pyridoxine hydrochloride
  • Pyridoxal phosphate
  • Carbon tetrachloride
  • Water

DownStream

  • Pyridoxal phosphate

Customs

[ HS Code ]: 2933399090

[ Summary ]:
2933399090. other compounds containing an unfused pyridine ring (whether or not hydrogenated) in the structure. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0%

Related Compounds

  • 4-Deoxypyridoxine 5'-phosphate
  • (5-HYDROXY-6-METHYLPYRIDINE-3,4-DIYL)DIMETHANOL 2-OXOPENTANEDIOATE
  • Pyridoxal 5'-phosphate
  • cytidine 5'-phosphate 2',3'-cyclic phosphate
  • Guanosine 5'-phosphate disodium salt hydrate
  • cytidine 5'-phosphate imidazolide
  • 4-(dimethylsulfamoyl)-N-[5-[(3-nitrophenyl)methylsulfanyl]-1,3,4-thiadiazol-2-yl]benzamide
  • N-[5-[2-[(2-chlorophenyl)methylamino]-2-oxo-ethyl]sulfanyl-1,3,4-thiadiazol-2-yl]-4-(dimethylsulfamoyl)benzamide
  • N-[5-[(2-chlorophenyl)methylsulfanyl]-1,3,4-thiadiazol-2-yl]-4-(dimethylsulfamoyl)benzamide
  • 2,2-dimethyl-N-[5-[2-oxo-2-[4-(trifluoromethyl)anilino]ethyl]sulfanyl-1,3,4-thiadiazol-2-yl]propanamide
  • 2,2-dimethyl-N-[5-[2-oxo-2-[4-(trifluoromethoxy)anilino]ethyl]sulfanyl-1,3,4-thiadiazol-2-yl]propanamide
  • ethyl 2-[[2-[[5-(2,2-dimethylpropanoylamino)-1,3,4-thiadiazol-2-yl]sulfanyl]acetyl]amino]benzoate
  • N-[5-[2-(3,4-dichloroanilino)-2-oxo-ethyl]sulfanyl-1,3,4-thiadiazol-2-yl]-2,2-dimethyl-propanamide
  • 3,4-dimethyl-N-[5-[2-oxo-2-[3-(trifluoromethyl)anilino]ethyl]sulfanyl-1,3,4-thiadiazol-2-yl]benzamide
  • N-[5-[2-(1,3-benzodioxol-5-ylamino)-2-oxo-ethyl]sulfanyl-1,3,4-thiadiazol-2-yl]-3-phenyl-propanamide
  • N-[5-[2-(2,3-dihydro-1,4-benzodioxin-6-ylamino)-2-oxo-ethyl]sulfanyl-1,3,4-thiadiazol-2-yl]-3-phenyl-propanamide
The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.